Regeneron Pharmaceuticals, Inc.

Qube Research & Technologies Ltd REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

142,183

Value ($000)

109,747

Weight

0.2%

2020 Q3 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	109,747	0.2%	142,183	12/31/2025
2025 Q3	11/14/2025	308,537	0.4%	548,734	9/30/2025
2025 Q2	8/14/2025	328,640	0.5%	625,980	6/30/2025
2025 Q1	5/15/2025	445,795	0.7%	702,892	3/31/2025
2024 Q4	2/14/2025	314,603	0.5%	441,654	12/31/2024
2024 Q3	11/14/2024	159,756	0.3%	151,969	9/30/2024
2024 Q2	8/14/2024	203,845	0.4%	193,948	6/30/2024
2024 Q1	5/14/2024	150,002	0.3%	155,848	3/31/2024
2023 Q4	2/13/2024	150,507	0.3%	171,364	12/31/2023
2023 Q3	11/13/2023	4,726	0.0%	5,743	9/30/2023
2023 Q1	5/15/2023	3,713	0.0%	4,519	3/31/2023
2022 Q4	2/14/2023	76,968	0.5%	106,679	12/31/2022
2022 Q3	11/14/2022	5,293	0.0%	7,683	9/30/2022
2022 Q2	8/15/2022	48,916	0.4%	82,750	6/30/2022
2022 Q1	5/9/2022	6,726	0.1%	9,630	3/31/2022
2021 Q4	2/10/2022	13,047	0.1%	20,660	12/31/2021
2021 Q3	11/12/2021	22,177	0.3%	36,645	9/30/2021
2020 Q4	2/16/2021	12,861	0.2%	26,622	12/31/2020
2020 Q3	11/12/2020	13,138	0.2%	23,470	9/30/2020